Their study showed that CCL3, produced by myeloma cells, induced the release of HMGB1 by osteocytes, which in turn stimulated RANKL expression, a key driver of osteoclast activation and bone resorption. The gene discussed is CCL3; the disease is plasma cell myeloma.